Fresenius Medical Care AG & Co. KGaAFMSNYSE
Loading
R&D Expense Growth AcceleratingAccelerating
Percentile Rank100
3Y CAGR+602.5%
5Y CAGR+80.3%
Year-over-Year Change
Year-over-year research & development expense growth
3Y CAGR
+602.5%/yr
vs -61.2%/yr prior
5Y CAGR
+80.3%/yr
Recent acceleration
Acceleration
+663.7pp
Accelerating
Percentile
P100
Near historical high
vs 5Y Ago
19.1x
Strong expansion
Streak
3 qtr
Consecutive growthAccelerating
| Period | Value |
|---|---|
| Q4 2025 | 318.57% |
| Q3 2025 | -0.97% |
| Q2 2025 | -12.34% |
| Q1 2025 | -13.89% |
| Q4 2024 | 26.23% |
| Q3 2024 | -13.04% |
| Q2 2024 | -3.77% |
| Q1 2024 | -27.56% |
| Q4 2023 | 24.50% |
| Q3 2023 | -7.02% |
| Q2 2023 | 1.79% |
| Q1 2023 | -9.75% |
| Q4 2022 | 0.92% |
| Q3 2022 | 10.95% |
| Q2 2022 | 11.57% |
| Q1 2022 | -26.69% |
| Q4 2021 | 29.40% |
| Q3 2021 | 0.66% |
| Q2 2021 | 6.93% |
| Q1 2021 | -7.22% |
| Q4 2020 | 16.71% |
| Q3 2020 | -11.05% |
| Q2 2020 | 9.99% |
| Q1 2020 | 46.06% |
| Q4 2019 | -36.07% |
| Q3 2019 | 19.88% |
| Q2 2019 | 22.03% |
| Q1 2019 | -11.54% |
| Q4 2018 | 47.62% |
| Q3 2018 | -31.62% |
| Q2 2018 | 17.65% |
| Q1 2018 | -11.11% |
| Q4 2017 | 29.99% |
| Q3 2017 | -21.09% |
| Q2 2017 | 9.21% |
| Q2 2017 | -19.53% |
| Q4 2016 | 2.06% |
| Q3 2016 | 12.28% |
| Q2 2016 | 5.39% |
| Q1 2016 | -9.62% |